BIOATLA, INC. Related Party Transaction, Amounts of Transaction
BIOATLA, INC. (BCAB) reported Related Party Transaction, Amounts of Transaction of $975.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:RelatedPartyTransactionAmountsOfTransaction · last filed 2026-08-13
- BIOATLA, INC. related party transaction, amounts of transaction for the quarter ending 2026-06-30 was $975.00K.
- BIOATLA, INC. related party transaction, amounts of transaction for the quarter ending 2025-12-31 was $300.00K, a 140.00% increase year-over-year.
- BIOATLA, INC. related party transaction, amounts of transaction for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- BIOATLA, INC. related party transaction, amounts of transaction for the quarter ending 2025-06-30 was $0.00.
- BIOATLA, INC. related party transaction, amounts of transaction for fiscal 2025 was $300.00K, a 86.05% decline from fiscal 2024.
- BIOATLA, INC. related party transaction, amounts of transaction for fiscal 2024 was $2.15M.
| Period end | Related Party Transaction, Amounts of Transaction 3 month | Related Party Transaction, Amounts of Transaction 6 month | Related Party Transaction, Amounts of Transaction 9 month | Related Party Transaction, Amounts of Transaction 12 month |
|---|---|---|---|---|
| 2026-06-30 | $975.00K 10-Q · filed 2026-08-13 | $975.00K 10-Q · filed 2026-08-13 | ||
| 2025-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $300.00K derived: sum of 2 quarters · filed 2026-03-31 | $300.00K derived: sum of 3 quarters · filed 2026-08-13 | $300.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $0.00 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | ||
| 2024-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.90M derived: sum of 2 quarters · filed 2026-03-31 | $2.15M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $1.77M 10-Q · filed 2025-11-13 | $2.02M 10-Q · filed 2025-11-13 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | $125.00K 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |